Corina E. Antal

1.5k total citations
19 papers, 743 citations indexed

About

Corina E. Antal is a scholar working on Molecular Biology, Oncology and Complementary and alternative medicine. According to data from OpenAlex, Corina E. Antal has authored 19 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Complementary and alternative medicine. Recurrent topics in Corina E. Antal's work include Protein Kinase Regulation and GTPase Signaling (11 papers), Natural Compounds in Disease Treatment (3 papers) and CRISPR and Genetic Engineering (3 papers). Corina E. Antal is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (11 papers), Natural Compounds in Disease Treatment (3 papers) and CRISPR and Genetic Engineering (3 papers). Corina E. Antal collaborates with scholars based in United States, United Kingdom and Switzerland. Corina E. Antal's co-authors include Alexandra C. Newton, Emily L. Kang, Natalie L. Stephenson, Eleanor W. Trotter, John Brognard, Tony Hunter, Frank B. Furnari, Lisa L. Gallegos, Andrew Hudson and Christopher Wirth and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Cancer Research.

In The Last Decade

Corina E. Antal

19 papers receiving 737 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Corina E. Antal United States	12	555	107	84	57	57	19	743
Shuiliang Yu United States	18	592 1.1×	62 0.6×	85 1.0×	88 1.5×	68 1.2×	25	796
Zhu Chen China	2	493 0.9×	85 0.8×	78 0.9×	35 0.6×	61 1.1×	4	707
Christine M. Gould United States	9	794 1.4×	154 1.4×	89 1.1×	66 1.2×	71 1.2×	10	963
Jae Cheal Yoo South Korea	16	503 0.9×	149 1.4×	124 1.5×	42 0.7×	56 1.0×	29	689
Hee-Sae Park South Korea	18	495 0.9×	70 0.7×	89 1.1×	53 0.9×	73 1.3×	31	663
Irina Baburina United States	13	430 0.8×	114 1.1×	88 1.0×	56 1.0×	69 1.2×	22	762
Michelle D. Armstrong United States	8	484 0.9×	148 1.4×	56 0.7×	94 1.6×	56 1.0×	8	640
Mamoru Aoto Japan	13	610 1.1×	92 0.9×	129 1.5×	79 1.4×	64 1.1×	19	840
Alexios-Leandros Skaltsounis Greece	3	523 0.9×	54 0.5×	65 0.8×	39 0.7×	23 0.4×	4	708

Countries citing papers authored by Corina E. Antal

Since Specialization

Citations

This map shows the geographic impact of Corina E. Antal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Corina E. Antal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Corina E. Antal more than expected).

Fields of papers citing papers by Corina E. Antal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Corina E. Antal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Corina E. Antal. The network helps show where Corina E. Antal may publish in the future.

Co-authorship network of co-authors of Corina E. Antal

This figure shows the co-authorship network connecting the top 25 collaborators of Corina E. Antal. A scholar is included among the top collaborators of Corina E. Antal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Corina E. Antal. Corina E. Antal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Propper, David, Erkut Borazanci, Peter J. O’Dwyer, et al.. (2024). Abstract CT218: Phase II open label trial of Minnelide™ in patients with chemotherapy refractory metastatic pancreatic cancer. Cancer Research. 84(7_Supplement). CT218–CT218. 1 indexed citations

Kunkel, Maya T., Timothy R. Baffi, Gema Lordén, et al.. (2021). Protein kinase C fusion proteins are paradoxically loss of function in cancer. Journal of Biological Chemistry. 296. 100445–100445. 22 indexed citations

Noel, Pawan, Shaimaa Hussein, Serina Ng, et al.. (2020). Triptolide targets super-enhancer networks in pancreatic cancer cells and cancer-associated fibroblasts. Oncogenesis. 9(11). 100–100. 45 indexed citations

Kunkel, Maya T., et al.. (2020). Protein Kinase C Fusions Reveal Another Mechanism for Loss of Protein Kinase C Function in Cancer. The FASEB Journal. 34(S1). 1–1. 1 indexed citations

Propper, David, Haiyong Han, Daniel D. Von Hoff, et al.. (2019). Abstract CT165: Phase II open label trial of minnelide™ in patients with chemotherapy refractory metastatic pancreatic cancer. Cancer Research. 79(13_Supplement). CT165–CT165. 5 indexed citations

Propper, David, Haiyong Han, Daniel D. Von Hoff, et al.. (2019). Abstract CT165: Phase II open label trial of minnelide™ in patients with chemotherapy refractory metastatic pancreatic cancer. Clinical Trials. CT165–CT165. 2 indexed citations

Newton, Alexandra C., Corina E. Antal, & Susan F. Steinberg. (2016). Protein kinase C mechanisms that contribute to cardiac remodelling. Clinical Science. 130(17). 1499–1510. 47 indexed citations

Callender, Julia A., Basavaraj Hooli, Corina E. Antal, et al.. (2016). Gain-of-function mutations in protein kinase Cα (PKCα) may promote synaptic defects in Alzheimer’s disease. Science Signaling. 9(427). ra47–ra47. 69 indexed citations

Antal, Corina E., Julia A. Callender, Alexandr P. Kornev, Susan S. Taylor, & Alexandra C. Newton. (2015). Intramolecular C2 Domain-Mediated Autoinhibition of Protein Kinase C βII. Cell Reports. 12(8). 1252–1260. 44 indexed citations

10.

Antal, Corina E., Andrew Hudson, Emily L. Kang, et al.. (2015). Cancer-Associated Protein Kinase C Mutations Reveal Kinase’s Role as Tumor Suppressor. Cell. 160(3). 489–502. 263 indexed citations

11.

Antal, Corina E., Andrew Hudson, Emily L. Kang, et al.. (2015). Abstract 125: Protein kinase C loss-of-function mutations in cancer reveal role as tumor suppressor. Cancer Research. 75(15_Supplement). 125–125. 2 indexed citations

12.

Antal, Corina E., Jonathan D. Violin, Maya T. Kunkel, Søs Skovsø, & Alexandra C. Newton. (2014). Intramolecular Conformational Changes Optimize Protein Kinase C Signaling. Chemistry & Biology. 21(4). 459–469. 48 indexed citations

13.

Antal, Corina E. & Alexandra C. Newton. (2014). Tuning the signalling output of protein kinase C. Biochemical Society Transactions. 42(6). 1477–1483. 51 indexed citations

14.

Antal, Corina E., Emily L. Kang, Natalie L. Stephenson, et al.. (2014). Prevalence of inactivating protein kinase C mutations in human cancers (1055.2). The FASEB Journal. 28(S1). 1 indexed citations

15.

Scott, A. M., Corina E. Antal, & Alexandra C. Newton. (2013). Electrostatic and Hydrophobic Interactions Differentially Tune Membrane Binding Kinetics of the C2 Domain of Protein Kinase Cα. Journal of Biological Chemistry. 288(23). 16905–16915. 22 indexed citations

16.

Antal, Corina E. & Alexandra C. Newton. (2013). Spatiotemporal Dynamics of Phosphorylation in Lipid Second Messenger Signaling. Molecular & Cellular Proteomics. 12(12). 3498–3508. 37 indexed citations

17.

Antal, Corina E., Anthony E. Boitano, Ying Wang, et al.. (2012). Euphohelioscopin A Is a PKC Activator Capable of Inducing Macrophage Differentiation. Chemistry & Biology. 19(8). 994–1000. 8 indexed citations

18.

Gould, Christine M., Corina E. Antal, Gloria Reyes, et al.. (2011). Active Site Inhibitors Protect Protein Kinase C from Dephosphorylation and Stabilize Its Mature Form. Journal of Biological Chemistry. 286(33). 28922–28930. 32 indexed citations

19.

Everett, Meredith V., Corina E. Antal, & D. L. Crawford. (2011). The effect of short‐term hypoxic exposure on metabolic gene expression. Journal of Experimental Zoology Part A Ecological Genetics and Physiology. 317A(1). 9–23. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact